The Korean Journal of Medicine

  • 제93권3호
  • /
  • Pages.271-276
  • /
  • 2018
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

류마티스 혈액 검사의 해석

Interpreting Rheumatologic Lab Tests

  • 김혜원 (분당서울대학교병원 내과학교실 종합내과)
  • Kim, Hye Won (Division of General Internal Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital)
  • 발행 : 2018.06.01
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Birtane M, Yavuz S, Tastekin N. Laboratory evaluation in rheumatic diseases. World J Methodol 2017;7:1-8. https://doi.org/10.5662/wjm.v7.i1.1
  2. Nilsson BO, Skogh T, Ernerudh J, et al. Antinuclear antibodies in the oldest-old women and men. J Autoimmun 2006;27:281-288. https://doi.org/10.1016/j.jaut.2006.10.002
  3. American collegy of rheumatology. Patient history form [Internet]. Atlanta (USA): American collegy of rheumatology, c2018 [cited 2018 Apr 3]. Available from: https://www.rheumatology.org/Portals/0/Files/New%20Patient%20History%20Form.pdf.
  4. Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor : more than an epiphenomenon? Circulation 1999;100:96-102. https://doi.org/10.1161/01.CIR.100.1.96
  5. Bochen K, Krasowska A, Milaniuk S, Kulczynska M, Prystupa A, Dzida G. Erythrocyte sedimentation rate-an old marker with new applications. J Pre-Clin Clin Res 2011;5:50-55.
  6. Emery P, Gabay C, Kraan M, Gomez-Reino J. Evidencebased review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis. Rheumatol Int 2007;27:793-806. https://doi.org/10.1007/s00296-007-0357-y
  7. Van der Heijde D, van 't Hof MA, van Riel PL, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-920. https://doi.org/10.1136/ard.49.11.916
  8. Ozgocmen S, Godekmerdan A, Ozkurt-Zengin F. Acute-phase response, clinical measures and disease activity in ankylosing spondylitis. Joint Bone Spine 2007;74:249-253. https://doi.org/10.1016/j.jbspin.2006.07.005
  9. van der Heijde D, Lie E, Kvien TK, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:1811-1818. https://doi.org/10.1136/ard.2008.100826
  10. Go DJ, Lee EY, Lee EB, Song YW, Konig MF, Park JK. Elevated erythrocyte sedimentation rate is predictive of interstitial lung disease and mortality in dermatomyositis: a Korean retrospective cohort study. J Korean Med Sci 2016;31:389-396. https://doi.org/10.3346/jkms.2016.31.3.389
  11. Mok C, Birmingham DJ, Ho LY, Hebert LA, Rovin BH. High sensitivity C-reactive protein, disease activity and cardiovascular risk factors in systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2013;65:441-447. https://doi.org/10.1002/acr.21841
  12. Walport MJ. Complement and systemic lupus erythematosus. Arthritis Research 2002;4 Suppl 3:S279-S293. https://doi.org/10.1186/ar586
  13. Visser H. Early diagnosis of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2005;19:55-72. https://doi.org/10.1016/j.berh.2004.08.005
  14. Lopez-Longo FJ, Sanchez-Ramon S, Carreno L. The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors? Drug News Perspect 2009;22:543-548. https://doi.org/10.1358/dnp.2009.22.9.1437962
  15. Satoh M, Vazquez-Del Mercado M, Chan EK. Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol 2009;19:219-228. https://doi.org/10.3109/s10165-009-0155-3
  16. Bossuyt X, Cohen Tervaert JW, Arimura Y, et al. Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 2017;13:683-692. https://doi.org/10.1038/nrrheum.2017.140

피인용 문헌

  1. 근골격계 질환에서 진단의학검사의 활용 vol.13, pp.2, 2018, https://doi.org/10.30581/jkcmm.2018.13.2.109